Farmers & Merchants Investments Inc. Buys 161 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Farmers & Merchants Investments Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,729 shares of the healthcare conglomerate’s stock after purchasing an additional 161 shares during the quarter. UnitedHealth Group comprises 1.2% of Farmers & Merchants Investments Inc.’s investment portfolio, making the stock its 12th biggest holding. Farmers & Merchants Investments Inc.’s holdings in UnitedHealth Group were worth $33,551,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the business. Kraft Davis & Associates LLC lifted its position in UnitedHealth Group by 3.4% in the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after acquiring an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC increased its stake in UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after buying an additional 19 shares during the last quarter. Secure Asset Management LLC increased its stake in UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after buying an additional 19 shares during the last quarter. Bensler LLC increased its stake in UnitedHealth Group by 0.3% in the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after buying an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX increased its stake in UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Down 6.4 %

Shares of NYSE:UNH opened at $458.16 on Wednesday. The firm has a fifty day moving average price of $500.89 and a two-hundred day moving average price of $518.93. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a market cap of $422.39 billion, a price-to-earnings ratio of 19.22, a PEG ratio of 1.33 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the previous year, the firm posted $5.34 EPS. The firm’s revenue was up 14.1% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 31.54%.

Analysts Set New Price Targets

Several equities research analysts have commented on UNH shares. HSBC reiterated a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Barclays began coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target for the company. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Finally, Oppenheimer restated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $579.33.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.